CoChat

Psychosocial interventions for people with both severe mental illness and substance misuse

Open access
Hunt, Glenn E, Siegfried, Nandi, Morley, Kirsten, Sitharthan, Thiagarajan, Cleary, Michelle · 2013 · Cochrane Database of Systematic Reviews
Cited by 116

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Even low levels of substance misuse by people with a severe mental illness can have detrimental effects. OBJECTIVES: To assess the effects of psychosocial interventions for reduction in substance use in people with a serious mental illness compared with standard care. SEARCH METHODS: For this update (2013), the Trials Search Co-ordinator of the Cochrane Schizophrenia Group (CSG) searched the CSG Trials Register (July 2012), which is based on regular searches of major medical and scientific databases. The principal authors conducted two further searches (8 October 2012 and 15 January 2013) of the Cochrane Database of Systematic Reviews, MEDLINE and PsycINFO. A separate search for trials of contingency management was completed as this was an additional intervention category for this update. SELECTION CRITERIA: We included all randomised controlled trials (RCTs) comparing psychosocial interventions for substance misuse with standard care in people with serious mental illness. DATA COLLECTION AND ANALYSIS: We independently selected studies, extracted data and appraised study quality. For binary outcomes, we calculated standard estimates of relative risk (RR) and their 95% confidence intervals (CI) on an intention-to-treat basis. For continuous outcomes, we calculated the mean difference (MD) between groups. For all meta-analyses we pooled data using a random-effects model. Using the GRADE approach, we identified seven patient-centred outcomes and assessed the quality of evidence for these within each comparison. MAIN RESULTS: We included 32 trials with a total of 3165 participants. Evaluation of long-term integrated care included four RCTs (n = 735). We found no significant differences on loss to treatment (n = 603, 3 RCTs, RR 1.09 CI 0.82 to 1.45, low quality of evidence), death by 3 years (n = 421, 2 RCTs, RR 1.18 CI 0.39 to 3.57, low quality of evidence), alcohol use (not in remission at 36 months) (n = 143, 1 RCT, RR 1.15 CI 0.84 to 1.56,low quality of evidence), substance use (n = 85, 1 RCT, RR 0.89 CI 0.63 to 1.25, low quality of evidence), global assessment of functioning (n = 171, 1 RCT, MD 0.7 CI 2.07 to 3.47, low quality of evidence), or general life satisfaction (n = 372, 2 RCTs, MD 0.02 higher CI 0.28 to 0.32, moderate quality of evidence).For evaluation of non-integrated intensive case management with usual treatment (4 RCTs, n = 163) we found no statistically significant difference for loss to treatment at 12 months (n = 134, 3 RCTs, RR 1.21 CI 0.73 to 1.99, very low quality of evidence).Motivational interviewing plus cognitive behavioural therapy compared to usual treatment (7 RCTs, total n = 878) did not reveal any advantage for retaining participants at 12 months (n = 327, 1 RCT, RR 0.99 CI 0.62 to 1.59, low quality of evidence) or for death (n = 493, 3 RCTs, RR 0.72 CI 0.22 to 2.41, low quality of evidence), and no benefit for reducing substance use (n = 119, 1 RCT, MD 0.19 CI -0.22 to 0.6, low quality of evidence), relapse (n = 36, 1 RCT, RR 0.5 CI 0.24 to 1.04, very low quality of evidence) or global functioning (n = 445, 4 RCTs, MD 1.24 CI 1.86 to 4.34, very low quality of evidence).Cognitive behavioural therapy alone compared with usual treatment (2 RCTs, n = 152) showed no significant difference for losses from treatment at 3 months (n = 152, 2 RCTs, RR 1.12 CI 0.44 to 2.86, low quality of evidence). No benefits were observed on measures of lessening cannabis use at 6 months (n = 47, 1 RCT, RR 1.30 CI 0.79 to 2.15, very low quality of evidence) or mental state (n = 105, 1 RCT, Brief Psychiatric Rating Scale MD 0.52 CI -0.78 to 1.82, low quality of evidence).We found no advantage for motivational interviewing alone compared with usual treatment (8 RCTs, n = 509) in reducing losses to treatment at 6 months (n = 62, 1 RCT, RR 1.71 CI 0.63 to 4.64, very low quality of evidence), although significantly more participants in the motivational interviewing group reported for their first aftercare appointment (n = 93, 1 RCT, RR 0.69 CI 0.53 to 0.9). Some differences, favouring treatment, were observed in abstaining from alcohol (n = 28, 1 RCT, RR 0.36 CI 0.17 to 0.75, very low quality of evidence) but not other substances (n = 89, 1 RCT, RR -0.07 CI -0.56 to 0.42, very low quality of evidence), and no differences were observed in mental state (n = 30, 1 RCT, MD 0.19 CI -0.59 to 0.21, very low quality of evidence).We found no significant differences for skills training in the numbers lost to treatment by 12 months (n = 94, 2 RCTs, RR 0.70 CI 0.44 to 1.1, very low quality of evidence).We found no differences for contingency management compared with usual treatment (2 RCTs, n = 206) in numbers lost to treatment at 3 months (n = 176, 1 RCT, RR 1.65 CI 1.18 to 2.31, low quality of evidence), number of stimulant positive urine tests at 6 months (n = 176, 1 RCT, RR 0.83 CI 0.65 to 1.06, low quality of evidence) or hospitalisations (n = 176, 1 RCT, RR 0.21 CI 0.05 to 0.93, low quality of eviden

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd001088.pub3

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 272

  1. Baker, 2002, Evaluation of a motivational interview for substance use within psychiatric inpatient services, Addiction, 97, 1329, 10.1046/j.1360-0443.2002.00178.x · DOI · Paper page
  2. Baker, 2002, Motivational interviewing among psychiatric inpatients with substance use disorders, Acta Psychiatrica Scandinavica, 106, 233, 10.1034/j.1600-0447.2002.01118.x · DOI · Paper page
  3. Baker, 2004, Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness, 1
  4. Baker, 2005, Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies, Psychiatry Research, 134, 241, 10.1016/j.psychres.2005.02.006 · DOI
  5. Barrowclough, 2001, Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders, American Journal of Psychiatry, 158, 1706, 10.1176/appi.ajp.158.10.1706 · DOI · Paper page
  6. Haddock, 2003, Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18-month outcomes of a randomised controlled trial, British Journal of Psychiatry, 183, 418, 10.1192/bjp.183.5.418 · DOI · Paper page
  7. Barrowclough, 2011, A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi-cbt) for people with a schizophrenia diagnosis and substance misuse - the MIDAS trial, Schizophrenia Bulletin, 37 Suppl 1, 295
  8. Barrowclough, 2006, Treatment development for psychosis and co-occurring substance misuse: a descriptive review, Journal of Mental Health, 15, 619, 10.1080/09638230600998920 · DOI
  9. Barrowclough, 2010, Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial, BMJ, 341, 6325, 10.1136/bmj.c6325 · DOI · Paper page
  10. Barrowclough, 2010, Predicting therapeutic alliance in clients with psychosis and substance misuse, Journal of Nervous and Mental Disease, 198, 373, 10.1097/NMD.0b013e3181da4d4e · DOI · Paper page
  11. Haddock, 2012, Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI-CBT fidelity scale (MI-CTS), Journal of Mental Health 2012;21(1):38-48, 21, 38
  12. Hartley, 2012, Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial, Behaviour Research and Therapy, 50, 65, 10.1016/j.brat.2011.10.007 · DOI
  13. Shabaruddin, 2011, Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co-occuring substance use: A UK based study, Value in Health, 14, A291, 10.1016/j.jval.2011.08.327 · DOI
  14. Bechdolf, 2011, State-dependent motivational interviewing for people with schizophrenia and substance use : Results of a randomised controlled trial, Nervenarzt, 83, 888, 10.1007/s00115-011-3331-6 · DOI
  15. Bellack, 2006, A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness, Archives of General Psychiatry, 63, 426, 10.1001/archpsyc.63.4.426 · DOI · Paper page
  16. Brown, 2011, Predictors of initiation and engagement in substance abuse treatment among individuals with co-occurring serious mental illness and substance use disorders, Addictive Behaviors, 36, 439, 10.1016/j.addbeh.2010.12.001 · DOI · Paper page
  17. Bond, 1991, Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems, Psychosocial Rehabilitation Journal, 15, 31, 10.1037/h0095785 · DOI
  18. Bond, 1991, Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems, Psychosocial Rehabilitation Journal, 15, 31, 10.1037/h0095785 · DOI
  19. Bonsack, 2010, Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial, Early Intervention in Psychiatry, 4 Suppl 1, 159
  20. Bonsack, 2011, Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial, Psychotherapy and Psychosomatics, 80, 287, 10.1159/000323466 · DOI · Paper page
  21. Burnam, 1995, An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults, Journal of Addictive Diseases, 14, 111, 10.1300/J069v14n04_07 · DOI · Paper page
  22. McGlynn, 1993, Treatment for the dually diagnosed homeless: program models and implementation experience: Los Angeles, Alcohol Treatment Quarterly, 10, 171, 10.1300/J020V10N03_14 · DOI
  23. Chandler, 2006, Integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders, Community Mental Health Journal, 42, 405, 10.1007/s10597-006-9055-6 · DOI
  24. Drake, 2006, The challenge of treating forensic dual diagnosis clients: comment on "Integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders", Community Mental Health Journal, 42, 427, 10.1007/s10597-006-9045-8 · DOI
  25. Clark, 1998, Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders, Health Services Research, 33, 1285
  26. Drake, 1998, Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial, American Journal of Orthopsychiatry, 68, 201, 10.1037/h0080330 · DOI · Paper page
  27. Edwards, 2006, Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis, Acta Psychiatrica Scandinavica, 114, 109, 10.1111/j.1600-0447.2006.00783.x · DOI · Paper page
  28. Essock, 2006, Comparison of ACT and Standard Case Management for Delivering Integrated Treatment for Co-occurring Disorders, Psychiatric Services, 57, 185, 10.1176/appi.ps.57.2.185 · DOI · Paper page
  29. Kanter J Clinical case management, case management and ACT Psychiatric Services 2006 578 · DOI
  30. Manuel, 2009, A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co-occurring disorders, Dissertation Abstracts International Section A: Humanities and Social Sciences, 69, 4126
  31. Manuel, 2011, Does assertive community treatment increase medication adherence for people with co-occurring psychotic and substance use disorders?, Journal of the American Psychiatric Nurses Association, 17, 51, 10.1177/1078390310395586 · DOI · Paper page
  32. Godley, 1994, Final MISA Report
  33. Graeber, 2003, A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders, Community Mental Health Journal, 39, 189, 10.1023/A:1023371705506 · DOI
  34. Hellerstein, 1995, A prospective study of integrated outpatient treatment for substance-abusing schizophrenic patients, American Journal on Addictions, 4, 33, 10.1111/j.1521-0391.1995.tb00256.x · DOI · Paper page
  35. Hellerstein, 2001, Integrating services for schizophrenia and substance abuse, Psychiatric Quarterly, 72, 291, 10.1023/A:1010385114289 · DOI
  36. Hickman ME The effects of personal feedback on alcohol intake in dually diagnosed clients: an empirical study of William R. Miller's motivational enhancement therapy Unpublished thesis. University Graduate School, Dept. Counseling Psychology, Indiana University 1997
  37. Fohlmann, 2010, CapOpus. randomized clinical trial: Specialized addiction treatment (MI & CBT) versus treatment as usual for young patients with cannabis abuse and psychosis, Early Intervention in Psychiatry, 4 Suppl 1, 159
  38. Fohlmann, 2010, CapOpus. randomized clinical trial: Specialized addiction treatment (MI & CBT) versus treatment as usual for young patients with cannabis abuse and psychosis, Early Intervention in Psychiatry, 4 Suppl 1, 160
  39. Hjorthaj, 2010, Validity of self-reported cannabis use as measured by the timeline follow-back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder, Early Intervention in Psychiatry, 4 Suppl 1, 160
  40. Hjorthoj, 2008, Design paper: the CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis, Trials, 9, 42, 10.1186/1745-6215-9-42 · DOI
  41. Hjorthoj, 2010, Interim analysis of the CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis, Schizophrenia Research, 117, 190, 10.1016/j.schres.2010.02.245 · DOI
  42. Hjorthoj, 2011, Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (tlfb)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial, Addiction, 107, 1123, 10.1111/j.1360-0443.2011.03757.x · DOI · Paper page
  43. Hjorthoj, 2013, Test-retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis-use disorder, Nordic Journal of Psychiatry, 67, 159, 10.3109/08039488.2012.691544 · DOI
  44. Hjorthøj, 2013, Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial, Psychological Medicine, 43, 1499, 10.1017/S0033291712002255 · DOI · Paper page
  45. Nordentoft, 2009, Capopus trial: An observer-blinded rct of specialized addiction treatment versus standard treatment for young patients with cannabis, Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24-28; Lisbon Portugal, 24, S1178
  46. Jerrell, 1996, Cost-effective treatment for persons with dual disorders, New Directions for Mental Health Services, 70, 79, 10.1002/yd.23319960208 · DOI
  47. Jerrell, 1994, Cost-effectiveness of substance disorder interventions for people with severe mental illness, Journal of Mental Health Administration, 21, 283, 10.1007/BF02521335 · DOI
  48. Jerrell, 1995, Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders, Journal of Nervous and Mental Disease, 183, 566, 10.1097/00005053-199509000-00002 · DOI · Paper page
  49. Jerrell, 1999, Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs, Psychiatric Services, 50, 109, 10.1176/ps.50.1.109 · DOI · Paper page
  50. Jerrell, 1995, Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders, Journal of Nervous and Mental Disease, 183, 566, 10.1097/00005053-199509000-00002 · DOI · Paper page
  51. Kemp, 2007, Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems, Australasian Psychiatry, 15, 490, 10.1080/10398560701439665 · DOI
  52. Lehman, 1993, Rehabilitation for adults with severe mental illness and substance use disorders: a clinical trial, Journal of Nervous and Mental Disease, 181, 86, 10.1097/00005053-199302000-00003 · DOI · Paper page
  53. Madigan, 2013, A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness, Schizophrenia Research, 143, 138, 10.1016/j.schres.2012.10.018 · DOI
  54. McDonell, 2013, Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness, American Journal of Psychiatry, 170, 94, 10.1176/appi.ajp.2012.11121831 · DOI · Paper page
  55. Weiss, 2013, Contingency management for patients with serious mental illness and stimulant dependence, American Journal of Psychiatry, 170, 6, 10.1176/appi.ajp.2012.12101324 · DOI
  56. Calsyn, 2005, Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals, Criminal Behaviour and Mental Health, 15, 236, 10.1002/cbm.24 · DOI · Paper page
  57. Fletcher, 2008, Evaluation of treatment programs for dual disorder individuals: modeling longitudinal and mediation effects, Administration and Policy in Mental Health, 35, 319, 10.1007/s10488-008-0170-2 · DOI
  58. Morse, 2008, Integrated treatment for homeless clients with dual disorders: a quasi-experimental evaluation, Journal of Dual Diagnosis, 4, 219, 10.1080/15504260802072065 · DOI
  59. Morse, 2006, Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes, Community Mental Health Journal, 42, 377, 10.1007/s10597-006-9050-y · DOI
  60. Naeem, 2005, Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems, Cognitive Behaviour Therapy, 34, 207, 10.1080/16506070510010684 · DOI · Paper page
  61. Swanson, 1999, Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients, Journal of Nervous and Mental Disease, 187, 630, 10.1097/00005053-199910000-00007 · DOI · Paper page
  62. Tracy, 2007, Contingency management to reduce substance use in individuals who are homeless with co-occurring psychiatric disorders, American Journal of Drug and Alcohol Abuse, 33, 253, 10.1080/00952990601174931 · DOI · Paper page
  63. Audier, 2011, Money for medication: A randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with a psychotic disorder and co-morbid substance abuse, Schizophrenia Bulletin, 1, 294
  64. Bachmann, 1997, An integrated treatment program for dually diagnosed patients, Psychiatric Services, 48, 314, 10.1176/ps.48.3.314 · DOI
  65. Bagoien, 2011, Motivational interviewing to patients with comorbid substance use admitted to an acute psychiatric department, Psychiatrische Praxis, 38, S10, 10.1055/s-0031-1277785 · DOI
  66. Bagoien, 2013, The effects of motivational interviewing on patients with comorbid substance use admitted to a psychiatric emergency unit - a randomised controlled trial with two year follow-up, BMC Psychiatry, 13, 93, 10.1186/1471-244X-13-93 · DOI · Paper page
  67. Barrowclough, 2006, Group cognitive-behavioural therapy for schizophrenia, British Journal of Psychiatry, 189, 527, 10.1192/bjp.bp.106.021386 · DOI · Paper page
  68. Beebe, 2012, Motivational intervention increases exercise in schizophrenia and co-occurring substance use disorders, Schizophrenia Research, 135, 204, 10.1016/j.schres.2011.12.008 · DOI
  69. Bell, 2011, Cognitive remediation with work therapy in the initial phase of substance abuse treatment, Schizophrenia Bulletin, Suppl 1, 296
  70. Bennett, 2001, Treating substance abuse in schizophrenia: An initial report, Journal of Substance Abuse Treatment, 20, 163, 10.1016/S0740-5472(00)00167-7 · DOI
  71. Berk, 1999, A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomised controlled trial, International Clinical Psychopharmacology, 14, 177, 10.1097/00004850-199905030-00005 · DOI
  72. Biegel, 2009, Predictors of referral to supported employment among consumers with co-occurring mental and substance use disorders, Community Mental Health Journal, 45, 427, 10.1007/s10597-009-9242-3 · DOI
  73. Bowen, 2000, A controlled trial of cognitive behavioural treatment of panic in alcoholic inpatients with comorbid panic disorder, Addictive Behaviours, 25, 593, 10.1016/S0306-4603(99)00017-9 · DOI
  74. Caplan, 2006, Change in neurocognition by housing type and substance abuse among formerly homeless seriously mentally ill persons, Schizophrenia Research, 83, 77, 10.1016/j.schres.2005.11.013 · DOI
  75. Carey, 2001, Enhancing readiness-to-change substance abuse in persons with schizophrenia. A four-session motivation-based intervention, Behaviour Modification, 25, 331, 10.1177/0145445501253001 · DOI
  76. Carey, 2004, Reducing HIV-risk behavior among adults receiving outpatient psychiatric treatment: Results from a randomized controlled trial, Journal of Consulting and Clinical Psychology, 72, 252, 10.1037/0022-006X.72.2.252 · DOI · Paper page
  77. Carroll, 1991, A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy, American Journal of Drug and Alcohol Abuse, 17, 229, 10.3109/00952999109027549 · DOI · Paper page
  78. Carroll, 1998, Managing MICA clients in a modified therapeutic community with enhanced staffing, Journal of Substance Abuse Treatment, 15, 565, 10.1016/S0740-5472(98)00005-1 · DOI
  79. Ceron D Mondoni S Malbergier A Silva G Schizophrenia: the influence of acupuncture on cocaine addicted patients Conference presentation to 153rd Annual Meeting of the APA, May 13-18, Chicago 2000
  80. Cheng, 2007, Impact of supported housing on clinical outcomes: analysis of a randomized trial using multiple imputation technique, Journal of Nervous and Mental Disease, 195, 83, 10.1097/01.nmd.0000252313.49043.f2 · DOI · Paper page
  81. Clark, 2001, Family support and substance use outcomes for persons with mental illness and substance use disorders, Schizophrenia Bulletin, 27, 93, 10.1093/oxfordjournals.schbul.a006862 · DOI · Paper page
  82. Conrad, 2006, randomized trial of psychiatric care with representative payeeship for persons with serious mental illness, Psychiatric Services, 57, 197, 10.1176/appi.ps.57.2.197 · DOI
  83. Craig, 2008, Integrated care for co-occurring disorders: psychiatric symptoms, social functioning, and service costs at 18 months, Psychiatric Services, 59, 276, 10.1176/ps.2008.59.3.276 · doi:10.1176/ps.2008.59.3.276 · Paper page
  84. Crump, 1996, The efficacy of substance abuse education among dual-diagnosis patients, Journal of Substance Abuse Treatment, 13, 141, 10.1016/0740-5472(96)00042-6 · doi:10.1016/0740-5472(96)00042-6
  85. D'Ercole, 1997, Effects of diagnosis, demographic characteristics, and case management on rehospitalization, Psychiatric Services, 48, 682, 10.1176/ps.48.5.682 · DOI
  86. Dalack, 1999, Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia, Neuropsychopharmacology, 21, 195, 10.1016/S0893-133X(98)00121-3 · DOI
  87. Daley, 1998, Increasing treatment adherence among outpatients with depression and cocaine dependence: Results of a pilot study, American Journal of Psychiatry, 155, 1611, 10.1176/ajp.155.11.1611 · DOI · Paper page
  88. DeMarce, 2008, Promoting continuing care adherence among substance abusers with co-occurring psychiatric disorders following residential treatment, Addictive Behaviors, 33, 1104, 10.1016/j.addbeh.2008.02.008 · DOI
  89. Drake, 2004, Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders, Biological Psychiatry, 56, 749, 10.1016/j.biopsych.2004.08.020 · DOI
  90. Drake, 2006, Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders, Schizophrenia Bulletin., 32, 464, 10.1093/schbul/sbj064 · DOI · Paper page
  91. Drebing, 2005, The impact of enhanced incentives on vocational rehabilitation outcomes for dually diagnosed veterans, Journal of Applied Behavior Analysis, 38, 359, 10.1901/jaba.2005.100-03 · DOI · Paper page
  92. Drebing, 2007, Adding contingency management intervention to vocational rehabilitation: outcomes for dually diagnosed veterans, Journal of Rehabilitation Research and Development, 44, 851, 10.1682/JRRD.2006.09.0123 · DOI
  93. Eberhard, 2009, Secondary prevention of hazardous alcohol consumption in psychiatric out-patients: a randomised controlled study, Social Psychiatry and Psychiatric Epidemiology, 12, 1013, 10.1007/s00127-009-0023-7 · DOI
  94. Essock, 1995, Implementing assertive community treatment teams, Psychiatric Services, 46, 679, 10.1176/ps.46.7.679 · DOI · Paper page
  95. Faber, 2012, Continued cannabis use and outcome in first-episode psychosis: Data from a randomized, open-label, controlled trial, Journal of Clinical Psychiatry, 73, 632, 10.4088/JCP.11m07069 · DOI · Paper page
  96. Fisher, 1996, Two group therapy models for clients with a dual diagnosis of substance abuse and personality disorder, Psychiatric Services, 47, 1244, 10.1176/ps.47.11.1244 · DOI
  97. Leon, 2000, Modified therapeutic community for homeless mentally ill chemical abusers: treatment outcomes, American Journal of Drug and Alcohol Abuse, 26, 461, 10.1081/ADA-100100256 · DOI
  98. French, 1999, Modified therapeutic community for mentally ill chemical abusers: outcomes and costs, Evaluation and the Health Professions, 22, 60, 10.1177/016327879902200104 · DOI
  99. Giannini, 2000, Acute ketamine intoxication treated by haloperidol: a preliminary study, American Journal of Therapeutics, 7, 389, 10.1097/00045391-200007060-00008 · DOI
  100. Godley, 2000, Case management for dually diagnosed individuals involved in the criminal justice system, Journal of Substance Abuse Treatment, 18, 137, 10.1016/S0740-5472(99)00027-6 · DOI
  101. Goldstein, 2005, Rehabilitation during alcohol detoxication in comorbid neuropsychiatric patients, Journal of Rehabilitation Research and Development, 42, 225, 10.1682/JRRD.2004.03.0040 · DOI
  102. Havassy, 2000, Effects of substance dependence on outcomes of patients in a randomized trial of two case management models, Psychiatric Services, 51, 639, 10.1176/appi.ps.51.5.639 · DOI · Paper page
  103. Hayes, 2003, Service enhancement to a dual-diagnosis population: Mental Illness/Substance Abuse (MISA), Quality Management in Health Care, 12, 133, 10.1097/00019514-200307000-00004 · DOI
  104. Hien, 2004, Promising treatment for women with comorbid PTSD and substance use disorders, American Journal of Psychiatry, 161, 1426, 10.1176/appi.ajp.161.8.1426 · DOI · Paper page
  105. Herman, 1997, Immediate outcomes of substance abuse treatment within a state psychiatric hospital, Journal of Mental Health Administration, 24, 126, 10.1007/BF02898508 · DOI
  106. Herman, 2000, Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders, Journal of Behavioral Health Services and Research, 27, 286, 10.1007/BF02291740 · DOI
  107. Hulse, 2002, Six-month outcomes associated with a brief alcohol intervention for adult in-patients with psychiatric disorders, Drug and Alcohol Review, 21, 105, 10.1080/09595230220138993a · DOI · Paper page
  108. Hurlburt, 1996, Effects of substance abuse on housing stability of homeless mentally ill persons in supported housing, Psychiatric Services, 47, 731, 10.1176/ps.47.7.731 · DOI · Paper page
  109. James, 2004, A group intervention which assists patients with dual diagnosis reduce their drug use: a randomized controlled trial, Psychological Medicine, 34, 983, 10.1017/S0033291703001648 · DOI · Paper page
  110. Jerrell, 2000, Issues and outcomes in integrated treatment programs for dual disorders, Journal of Behavioral Health Services & Research, 27, 303, 10.1007/BF02291741 · DOI
  111. Jones, 2011, Integrated motivational interviewing and cognitive-behavioural therapy for bipolar disorder with comorbid substance use, Clinical Psychology & Psychotherapy, 18, 426, 10.1002/cpp.783 · DOI
  112. Judd, 2003, A dual diagnosis demonstration project: treatment outcomes and cost analysis, Journal of Psychoactive Drugs, 35 Suppl 1, 181, 10.1080/02791072.2003.10400513 · DOI
  113. Kasprow, 1999, Residential treatment for dually diagnosed homeless veterans: a comparison of program types, American Journal on Addictions, 8, 34, 10.1080/105504999306063 · DOI
  114. Keet, 2006, Family motivational intervention: training motivational interviewing for family members of patients with schizophrenia, cannabis use and poor compliance, Schizophrenia Research, 86 Suppl 1, S149, 10.1016/S0920-9964(06)70445-5 · doi:10.1016/s0920-9964(06)70445-5
  115. Kelly, 2003, Major depression in patients with substance use disorders: relationship to 12-step self-help involvement and substance use outcomes, Addiction, 98, 499, 10.1046/j.1360-0443.2003.t01-1-00294.x · DOI · Paper page
  116. Lasser, 2000, The unique aspects of the realise program - a global development programme to assess the safety, efficacy and long-term impact of iloperidone in schizophrenia, International Journal of Neuropsychopharmacology, 3, S123
  117. Magura, 2003, Role of self-help processes in achieving abstinence among dually diagnosed persons, Addictive Behaviours, 28, 399, 10.1016/S0306-4603(01)00278-7 · DOI
  118. Martino, 2000, Motivational interviewing with psychiatrically ill substance abusing patients, The American Journal on Addictions, 9, 88, 10.1080/10550490050172263 · DOI · Paper page
  119. Martino, 2006, A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders, Addiction, 101, 1479, 10.1111/j.1360-0443.2006.01554.x · DOI · Paper page
  120. McGeary, 2000, Service use and cost by mentally ill chemical abusers: differences by retention in a therapeutic community, Journal of Substance Abuse, 11, 265, 10.1016/S0899-3289(00)00026-2 · DOI
  121. McGurk, 2009, Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation, Schizophrenia Bulletin, 35, 319, 10.1093/schbul/sbn182 · DOI · Paper page
  122. McHugo, 1999, Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study, Psychiatric Services, 50, 818, 10.1176/ps.50.6.818 · DOI · Paper page
  123. Mercer McFadden, 1997, The Community Support Program demonstrations of services for young adults with severe mental illness and substance use disorders, 1987-1991, Psychiatric Rehabilitation Journal, 20, 13, 10.1037/h0095368 · DOI
  124. Milby, 2000, Initiating abstinence in cocaine abusing dually diagnosed homeless persons, Drug & Alcohol Dependence, 60, 55, 10.1016/S0376-8716(00)80008-3 · DOI
  125. Mowbray, 1999, Analysis of postdischarge change in a dual diagnosis population, Health and Social Work, 24, 91, 10.1093/hsw/24.2.91 · DOI
  126. Mueser, 2001, Rural and urban differences in patients with a dual diagnosis, Schizophrenia Research, 48, 93, 10.1016/S0920-9964(00)00065-7 · DOI
  127. Mueser, 2009, Family intervention for co-occurring substance use and severe psychiatric disorders: participant characteristics and correlates of initial engagement and more extended exposure in a randomized controlled trial, Addictive Behaviors, 34, 867, 10.1016/j.addbeh.2009.03.025 · DOI · Paper page
  128. Mueser, 2010, Family psychoeducation with patients who have co-occurring substance use disorders and severe mental illness, Schizophrenia Research, 117, 121, 10.1016/j.schres.2010.02.059 · DOI
  129. Mueser, 2013, A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders, Schizophrenia Bulletin, 39, 658, 10.1093/schbul/sbr203 · DOI · Paper page
  130. Nuijten, 2012, A randomised controlled trial of outpatient versus inpatient integrated treatment of dual diagnosis patients: A failed but informative study, Mental Health and Substance Use: Dual Diagnosis, 5, 132, 10.1080/17523281.2011.628947 · DOI
  131. Nuttbrock, 1997, Pre- and post-admission attrition of homeless, mentally ill chemical abusers referred to residential treatment programs, Addiction, 92, 1305, 10.1111/j.1360-0443.1997.tb02849.x · DOI
  132. Nuttbrock, 1998, Outcomes of homeless mentally ill chemical abusers in community residences and a therapeutic community, Psychiatric Services, 49, 68, 10.1176/ps.49.1.68 · DOI · Paper page
  133. Rahav, 1995, Characteristics and treatment of homeless, mentally ill, chemical-abusing men, Journal of Psychoactive Drugs, 27, 93, 10.1080/02791072.1995.10471677 · DOI
  134. Otto-Salaj, 2001, Outcomes of a randomized small-group HIV prevention intervention trial for people with serious mental illness, Community Mental Health Journal, 37, 123, 10.1023/A:1002709715201 · DOI
  135. Brooks, 2003, Comparing treatments for dual diagnosis: Twelve-step and self-management and recovery training, The American Journal of Drug and Alcohol Abuse, 29, 359, 10.1081/ADA-120020519 · DOI · Paper page
  136. Penn, 2000, Five years, twelve steps, and REBT in the treatment of dual diagnosis, Journal of Rational-Emotive & Cognitive-Behavior Therapy, 18, 197, 10.1023/A:1007883021936 · DOI
  137. Petersen, 2006, Substance abuse in first-episode schizophrenia-spectrum disorders, Schizophrenia Research, 86 Suppl 1, S44, 10.1016/S0920-9964(06)70132-3 · DOI
  138. Petersen, 2007, Does cannabis abuse determine outcome among patients with first episode psychosis. Results from the OPUS-trial, Schizophrenia Bulletin, 33, 453
  139. Rahav, 1995, Characteristics and treatment of homeless, mentally ill, chemical-abusing men, Journal of Psychoactive Drugs, 27, 93, 10.1080/02791072.1995.10471677 · DOI
  140. Ries, 2004, Outcomes of managing disability benefits among patients with substance dependence and severe mental illness, Psychiatric Services, 55, 445, 10.1176/appi.ps.55.4.445 · DOI · Paper page
  141. Rosenheck, 1998, Cost-effectiveness of intensive psychiatric community care for high users of inpatient services, Archives of General Psychiatry, 55, 459, 10.1001/archpsyc.55.5.459 · DOI · Paper page
  142. Sacks, 2004, Modified TC for MICA offenders: crime outcomes, Behavioral Sciences and the Law, 22, 477, 10.1002/bsl.599 · DOI · Paper page
  143. Sacks, 2008, Prison therapeutic community treatment for female offenders: profiles and preliminary findings for mental health and other variables (crime, substance use and HIV risk), Journal of Offender Rehabilitation, 46, 233, 10.1080/10509670802143680 · DOI · Paper page
  144. Sullivan, 2007, Modified therapeutic community treatment for offenders with MICA disorders: substance use outcomes, American Journal of Drug and Alcohol Abuse, 33, 823, 10.1080/00952990701653800 · DOI · Paper page
  145. Samele, 2002, Non-alcohol substance misuse, outcome and intensive case management, European Psychiatry, 17 Suppl 1, 216s, 10.1016/S0924-9338(02)80923-3 · DOI
  146. Santa Ana, 2007, Efficacy of group motivational interviewing (GMI) for psychiatric inpatients with chemical dependence, Journal of Consulting and Clinical Psychology, 75, 816, 10.1037/0022-006X.75.5.816 · DOI
  147. Schaar, 2001, Severely mentally ill substance abusers: an 18 month follow-up study, Social Psychiatry Psychiatric Epidemiology, 36, 70, 10.1007/s001270170066 · DOI
  148. Schmitz, 2002, Cognitive-behavioral treatment of bipolar disorder and substance abuse: A preliminary randomized study, Addictive Disorders and Their Treatment, 1, 17, 10.1097/00132576-200205000-00004 · DOI · Paper page
  149. Sigmon, 2000, Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study, Experimental & Clinical Psychopharmacology, 8, 509, 10.1037/1064-1297.8.4.509 · doi:10.1037/1064-1297.8.4.509 · Paper page
  150. Siris, 1993, Adjunctive imipramine in substance-abusing dysphoric schizophrenic patients, Psychopharmacology Bulletin, 29, 127
  151. Sitharthan, 1999, Integrated drug and alcohol intervention: development of an opportunistic intervention program to reduce alcohol and other substance use among psychiatric patients, Australian and New Zealand Journal of Psychiatry, 33, 676, 10.1080/j.1440-1614.1999.00621.x · DOI
  152. Smeerdijk M Keet R De Haan L Schippers G Linszen D Family motivation intervention in early onset psychosis and cannabis abuse: a randomized clinical trial Proceedings of the 12th International Congress on Schizophrenia Research; 2009 Mar 28-Apr 1; San Diego, CA Oxford Univ Press 371
  153. Smeerdijk, 2010, Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent onset schizophrenia, Early Intervention in Psychiatry, 4 Suppl 1, 6
  154. Smeerdijk, 2012, Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial, Psychological Medicine, 42, 1627, 10.1017/S0033291711002832 · DOI
  155. Swanson, 2000, Involuntary out-patient commitment and reduction of violent behaviour in persons with severe mental illness, British Journal of Psychiatry, 176, 324, 10.1192/bjp.176.4.324 · DOI · Paper page
  156. Teague, 1995, Evaluating use of continuous treatment teams for persons with mental illness and substance abuse, Psychiatric Services, 46, 689, 10.1176/ps.46.7.689 · DOI · Paper page
  157. Hughes, 2008, Training in dual diagnosis interventions (the COMO Study): randomised controlled trial, BMC Psychiatry, 8, 12, 10.1186/1471-244X-8-12 · DOI · Paper page
  158. Johnson, 2007, Effects of training community staff in interventions for substance misuse in dual diagnosis patients with psychosis (COMO study): cluster randomised trial, British Journal of Psychiatry, 191, 451, 10.1192/bjp.bp.106.032367 · DOI
  159. Timko, 2006, Dual diagnosis patients in community or hospital care: one-year outcomes and health care utilization and costs, Journal of Mental Health, 15, 163, 10.1080/09638230600559631 · DOI
  160. Timko, 2004, Short-term outcomes of matching dual diagnosis patients' symptom severity to treatment intensity, Journal of Substance Abuse Treatment., 26, 209, 10.1016/S0740-5472(04)00002-9 · DOI
  161. Tyrer, 2011, Nidotherapy in the treatment of substance misuse, psychosis and personality disorder: Secondary analysis of a controlled trial, Psychiatrist, 35, 9, 10.1192/pb.bp.110.029983 · DOI
  162. Watt, 2006, Brief CBT for high anxiety sensitivity decreases drinking problems, relief alcohol outcome expectancies, and conformity drinking motives: evidence from a randomized controlled trial, Journal of Mental Health, 15, 683, 10.1080/09638230600998938 · DOI · Paper page
  163. Weaver, 2009, Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders, Journal of Mental Health Policy and Economics, 12, 33
  164. Weiss, 2000, Group therapy for patients with bipolar disorder and substance dependence: results of a pilot study, Journal of Clinical Psychiatry, 61, 361, 10.4088/JCP.v61n0507 · DOI · Paper page
  165. Worley, 2010, Service utilization during and after outpatient treatment for comorbid substance use disorder and depression, Journal of Substance Abuse Treatment, 39, 124, 10.1016/j.jsat.2010.05.009 · DOI
  166. Xie, 2005, Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders, Psychiatric Services, 56, 1282, 10.1176/appi.ps.56.10.1282 · DOI · Paper page
  167. Xie, 2005, Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders, Schizophrenia Research, 75, 337, 10.1016/j.schres.2004.07.012 · DOI
  168. Xie, 2006, Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group-based modeling approach, Administration and Policy in Mental Health and Mental Health Services, 33, 423, 10.1007/s10488-006-0048-0 · DOI
  169. Meister, 2010, A cluster-randomized, parallel group, observer blind trial of a group based motivational-behavioural therapy for young people with psychosis and substance use disorder, Early Intervention in Psychiatry, 4 Suppl 1, 163
  170. Meister K Comorbid psychosis and addiction. Epidemiology, explanatory models and evaluation of motivational behavioural group therapy Dissertation, University of Hamburg 2010
  171. Odom, 2005, A randomized study of integrated outpatient treatment and assertive community treatment for patients with comorbid mental illness and substance use disorders: comparing treatment outcome for domiciled and homeless patients [PhD thesis]
  172. Bennett, 2007, Treatment of alcohol use disorders in people with severe mental illness, Schizophrenia Bulletin, 33, 421
  173. Bennett, 2011, The effects of a group based behavioral approach to substance misuse and schizophrenia, Schizophrenia Bulletin, 1, 296
  174. Smith S Greenwood K Atakan Z Sood P Ohlsen R Papanastasiou E The impact study - motivating a change in health behaviour European Psychiatry 2011 · DOI
  175. Barrowclough, 2010, Helper recap: Rethinking choices after psychosis - a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis, Early Intervention in Psychiatry, 4 Suppl 1, 161
  176. Worrell L Helper programme (substance misuse)- a phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap) http://public.ukcrn.org.uk 2011 · DOI
  177. Altman, 2001, The revised CONSORT statement for reporting randomized trial: explanation and elaboration, Annals of Internal Medicine, 134, 663, 10.7326/0003-4819-134-8-200104170-00012 · DOI · Paper page
  178. Appleby, 1997, Assessing substance use in multiproblem patients: reliability and validity of the Addiction Severity Index in a mental hospital population, Journal of Nervous & Mental Disease, 185, 159, 10.1097/00005053-199703000-00005 · DOI · Paper page
  179. Asberg, 1978, A comprehensive psychopathological rating scale, Acta Psychiatrica Scandinavica Supplement, 271, 5, 10.1111/j.1600-0447.1978.tb02357.x · DOI · Paper page
  180. Baker, 2012, A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders, Acta Psychiatrica Scandinavica, 126, 243, 10.1111/j.1600-0447.2012.01885.x · DOI · Paper page
  181. Barrowclough, 2006, Treatment development for psychosis and co-occurring substance misuse: A descriptive review, Journal of Mental Health, 15, 619, 10.1080/09638230600998920 · DOI
  182. Beck, 1972, Screening depressed patients in family practice. A rapid technique, Postgraduate Medicine, 52, 81, 10.1080/00325481.1972.11713319 · DOI · Paper page
  183. Birchwood, 1990, The Social Functioning Scale: the development and validation of a scale of social adjustment for use in family intervention programmes with schizophrenic patients, British Journal of Psychiatry, 157, 853, 10.1192/bjp.157.6.853 · DOI · Paper page
  184. Bland, 1997, Trials randomised in clusters, BMJ, 315, 600, 10.1136/bmj.315.7108.600 · DOI · Paper page
  185. Bogenschutz, 2006, The role of twelve-step approaches in dual diagnosis treatment and recovery, American Journal on Addictions, 15, 50, 10.1080/10550490500419060 · DOI
  186. Boissel, 1999, The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use, Therapie, 54, 405
  187. Bond, 1988, Assertive case management in three CMHCs: a controlled study, Hospital and Community Psychiatry, 39, 411
  188. Bond, 1990, Assertive community treatment for frequent users of psychiatric hospitals in a large city: a controlled study, American Journal of Community Psychology, 18, 865, 10.1007/BF00938068 · DOI · Paper page
  189. Burns, 2007, Social functioning as an outcome measure in schizophrenia studies, Acta Psychiatrica Scandinavica, 116, 403, 10.1111/j.1600-0447.2007.01108.x · DOI · Paper page
  190. Carey, 1996, Concurrent validity of clinicians' rating of substance abuse among psychiatric outpatients, Psychiatric Services, 47, 842, 10.1176/ps.47.8.842 · DOI · Paper page
  191. Carra, 2009, Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review, Social Psychiatry & Psychiatric Epidemiology, 44, 429, 10.1007/s00127-008-0458-2 · DOI
  192. Chanut, 2005, Motivational interviewing and clinical psychiatry, Canadian Journal of Psychiatry, 50, 548, 10.1177/070674370505000908 · DOI · Paper page
  193. Cleary, 2009, Psychosocial treatments for people with co-occurring severe mental illness and substance misuse: systematic review, Journal of Advanced Nursing, 65, 238, 10.1111/j.1365-2648.2008.04879.x · DOI · Paper page
  194. Cleary, 2009, Conducting efficient literature searches. Strategies for mental health nurses, Journal of Psychosocial Nursing & Mental Health Services, 47, 34, 10.3928/02793695-20090930-03 · DOI
  195. Corse, 1995, The use of the Addiction Severity Index with people with severe mental illness, Psychiatric Rehabilitation Journal, 19, 9, 10.1037/h0095465 · DOI
  196. Darke, 1991, The Opiate Treatment Index (OTI) Researchers Manual. Technical report No. 11
  197. Darke, 1992, Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index, British Journal of Addiction, 87, 733, 10.1111/j.1360-0443.1992.tb02719.x · DOI · Paper page
  198. David, 1992, The assessment of insight in psychosis, British Journal of Psychiatry, 161, 599, 10.1192/bjp.161.5.599 · DOI · Paper page
  199. Derogatis, 1973, SCL-90: An outpatient psychiatric rating scale: Preliminary report, Psychopharmacology Bulletin, 9, 13
  200. Derogatis, 1975, Social class, psychological disorder, and the nature of the psychpathologic indicator, Journal of Consulting and Clinical Psychology, 43, 183, 10.1037/h0076514 · DOI

200 of 272 shown

Cited by

See all 116

Metadata

Authors
Hunt, G. E., Siegfried, N., Morley, K., Sitharthan, T., & Cleary, M.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2013-10-03
Issue
10
Pages
CD001088-CD001088
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W4236645313
Cited by
116
References
53
FWCI
10.81
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.